These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21273509)

  • 1. Plasma N-glycan profiling by mass spectrometry for congenital disorders of glycosylation type II.
    Guillard M; Morava E; van Delft FL; Hague R; Körner C; Adamowicz M; Wevers RA; Lefeber DJ
    Clin Chem; 2011 Apr; 57(4):593-602. PubMed ID: 21273509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution mass spectrometry glycoprofiling of intact transferrin for diagnosis and subtype identification in the congenital disorders of glycosylation.
    van Scherpenzeel M; Steenbergen G; Morava E; Wevers RA; Lefeber DJ
    Transl Res; 2015 Dec; 166(6):639-649.e1. PubMed ID: 26307094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MALDI-MS profiling of serum O-glycosylation and N-glycosylation in COG5-CDG.
    Palmigiano A; Bua RO; Barone R; Rymen D; Régal L; Deconinck N; Dionisi-Vici C; Fung CW; Garozzo D; Jaeken J; Sturiale L
    J Mass Spectrom; 2017 Jun; 52(6):372-377. PubMed ID: 28444691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative quantification of plasma N-glycans in type II congenital disorder of glycosylation patients by mass spectrometry.
    Barbosa EA; Fontes NDC; Santos SCL; Lefeber DJ; Bloch C; Brum JM; Brand GD
    Clin Chim Acta; 2019 May; 492():102-113. PubMed ID: 30776362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Clinical Sensitivity and Specificity of Plasma Protein
    Chen J; Li X; Edmondson A; Meyers GD; Izumi K; Ackermann AM; Morava E; Ficicioglu C; Bennett MJ; He M
    Clin Chem; 2019 May; 65(5):653-663. PubMed ID: 30770376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein C-III O-glycoform profiling of 500 serum samples by matrix-assisted laser desorption/ionization mass spectrometry for diagnosis of congenital disorders of glycosylation.
    Wada Y; Okamoto N
    J Mass Spectrom; 2021 Apr; 56(4):e4597. PubMed ID: 32677746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum N-glycan and O-glycan analysis by mass spectrometry for diagnosis of congenital disorders of glycosylation.
    Xia B; Zhang W; Li X; Jiang R; Harper T; Liu R; Cummings RD; He M
    Anal Biochem; 2013 Nov; 442(2):178-85. PubMed ID: 23928051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MALDI-TOF MS applied to apoC-III glycoforms of patients with congenital disorders affecting O-glycosylation. Comparison with two-dimensional electrophoresis.
    Yen-Nicolaÿ S; Boursier C; Rio M; Lefeber DJ; Pilon A; Seta N; Bruneel A
    Proteomics Clin Appl; 2015 Aug; 9(7-8):787-93. PubMed ID: 25641685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling human congenital disorder of glycosylation type IIa in the mouse: conservation of asparagine-linked glycan-dependent functions in mammalian physiology and insights into disease pathogenesis.
    Wang Y; Tan J; Sutton-Smith M; Ditto D; Panico M; Campbell RM; Varki NM; Long JM; Jaeken J; Levinson SR; Wynshaw-Boris A; Morris HR; Le D; Dell A; Schachter H; Marth JD
    Glycobiology; 2001 Dec; 11(12):1051-70. PubMed ID: 11805078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbohydrate-deficient glycoprotein syndrome type II.
    Schachter H; Jaeken J
    Biochim Biophys Acta; 1999 Oct; 1455(2-3):179-92. PubMed ID: 10571011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new method for the rapid diagnosis of protein N-linked congenital disorders of glycosylation.
    Heywood WE; Mills P; Grunewald S; Worthington V; Jaeken J; Carreno G; Lemonde H; Clayton PT; Mills K
    J Proteome Res; 2013 Jul; 12(7):3471-9. PubMed ID: 23742123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass spectrometry glycophenotype characterization of ALG2-CDG in Argentinean patients with a new genetic variant in homozygosis.
    Papazoglu GM; Cubilla M; Pereyra M; de Kremer RD; Pérez B; Sturiale L; Asteggiano CG
    Glycoconj J; 2021 Apr; 38(2):191-200. PubMed ID: 33644825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural determination of N-linked carbohydrates by matrix-assisted laser desorption/ionization-mass spectrometry following enzymatic release within sodium dodecyl sulphate-polyacrylamide electrophoresis gels: application to species-specific glycosylation of alpha1-acid glycoprotein.
    Küster B; Hunter AP; Wheeler SF; Dwek RA; Harvey DJ
    Electrophoresis; 1998 Aug; 19(11):1950-9. PubMed ID: 9740055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into complexity of congenital disorders of glycosylation.
    Goreta SS; Dabelic S; Dumic J
    Biochem Med (Zagreb); 2012; 22(2):156-70. PubMed ID: 22838182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital disorders of glycosylation type I leads to altered processing of N-linked glycans, as well as underglycosylation.
    Mills P; Mills K; Clayton P; Johnson A; Whitehouse D; Winchester B
    Biochem J; 2001 Oct; 359(Pt 2):249-54. PubMed ID: 11583570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycosylation Analysis for Congenital Disorders of Glycosylation.
    Li X; Raihan MA; Reynoso FJ; He M
    Curr Protoc Hum Genet; 2015 Jul; 86():17.18.1-17.18.22. PubMed ID: 26132001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rapid mass spectrometric strategy for the characterization of N- and O-glycan chains in the diagnosis of defects in glycan biosynthesis.
    Faid V; Chirat F; Seta N; Foulquier F; Morelle W
    Proteomics; 2007 Jun; 7(11):1800-13. PubMed ID: 17520685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALG12-CDG: novel glycophenotype insights endorse the molecular defect.
    Sturiale L; Bianca S; Garozzo D; Terracciano A; Agolini E; Messina A; Palmigiano A; Esposito F; Barone C; Novelli A; Fiumara A; Jaeken J; Barone R
    Glycoconj J; 2019 Dec; 36(6):461-472. PubMed ID: 31529350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the N-glycosylation phenotype of erythrocyte membrane proteins in congenital dyserythropoietic anemia type II (CDA II/HEMPAS).
    Denecke J; Kranz C; Nimtz M; Conradt HS; Brune T; Heimpel H; Marquardt T
    Glycoconj J; 2008 May; 25(4):375-82. PubMed ID: 18166993
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.